DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 077782
The generic ingredient in CIPROFLOXACIN is ciprofloxacin hydrochloride. There are thirty-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
Summary for 077782
Tradename: | CIPROFLOXACIN |
Applicant: | Teva Pharms Usa |
Ingredient: | ciprofloxacin |
Patents: | 0 |
Therapeutic Class: | Antibacterials |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 077782
Ingredient-type | Quinolones |
Medical Subject Heading (MeSH) Categories for 077782
Suppliers and Packaging for NDA: 077782
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CIPROFLOXACIN | ciprofloxacin | INJECTABLE;INJECTION | 077782 | ANDA | Rebel Distributors Corp | 21695-422 | E | 21695-422-01 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/20ML (10MG/ML) | ||||
Approval Date: | Aug 28, 2006 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 400MG/40ML (10MG/ML) | ||||
Approval Date: | Aug 28, 2006 | TE: | RLD: | No |
Complete Access Available with Subscription